Direct Acting Antiviral Drugs: Pharmacokinetics and Drug-Drug Interactions
Hepatitis C (HCV) is a widespread health issue, which can lead to hepatic cirrhosis, liver failure, and liver cancer. Nearly 2% of the world's population or > 185 million people are chronically infected with HCV; the management of HCV and the rate of sustained virological response (SVR) were...
Saved in:
Main Authors: | Marina Barakat (Author), Sara Wahdan (Author), Azza Awad (Author), Ebtehal El-Demerdash Zaki (Author) |
---|---|
Format: | Book |
Published: |
Ain Shams University,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug-drug interactions between antithrombotics and direct-acting antivirals in hepatitis C virus (HCV) patients: A brief, updated report
by: Mario Enrico Canonico, et al.
Published: (2022) -
Venetoclax (ABT-199) Might Act as a Perpetrator in Pharmacokinetic Drug-Drug Interactions
by: Johanna Weiss, et al.
Published: (2016) -
Pharmacokinetic Drug-Drug Interactions and Herb-Drug Interactions
by: Min-Koo Choi, et al.
Published: (2021) -
Hepatitis C virus infection: Epidemiology in Egypt, Pathophysiology and DAAs-based therapy
by: Heba Elbadawy, et al.
Published: (2021) -
Role of different direct-acting antiviral drugs on hepatitis C virus-associated mixed cryoglobulinemia in Egyptian patients
by: Tarek A Elshazly, et al.
Published: (2019)